Correlation Between Progate and Tsh Biopharmoration

Can any of the company-specific risk be diversified away by investing in both Progate and Tsh Biopharmoration at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Progate and Tsh Biopharmoration into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Progate Group and tsh biopharmoration, you can compare the effects of market volatilities on Progate and Tsh Biopharmoration and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Progate with a short position of Tsh Biopharmoration. Check out your portfolio center. Please also check ongoing floating volatility patterns of Progate and Tsh Biopharmoration.

Diversification Opportunities for Progate and Tsh Biopharmoration

-0.43

Correlation Coefficient

Progate  Tsh Biopharmoration

Very good diversification

The 3 months correlation between Progate and Tsh is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding Progate Group and tsh biopharmoration in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on tsh biopharmoration and Progate is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Progate Group are associated (or correlated) with Tsh Biopharmoration. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of tsh biopharmoration has no effect on the direction of Progate i.e., Progate and Tsh Biopharmoration go up and down completely randomly.

Pair Corralation between Progate and Tsh Biopharmoration

Assuming the 90 days trading horizon Progate Group is expected to under-perform the Tsh Biopharmoration. In addition to that, Progate is 2.55 times more volatile than tsh biopharmoration. It trades about -0.01 of its total potential returns per unit of risk. tsh biopharmoration is currently generating about -0.03 per unit of volatility. If you would invest  6,280  in tsh biopharmoration on October 9, 2024 and sell it today you would lose (60.00) from holding tsh biopharmoration or give up 0.96% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Progate Group  vs.  tsh biopharmoration

Progate Group

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Progate Group are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Progate is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

tsh biopharmoration

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days tsh biopharmoration has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Tsh Biopharmoration is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.

Pair Trading with Progate and Tsh Biopharmoration

The main advantage of trading using opposite Progate and Tsh Biopharmoration positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Progate position performs unexpectedly, Tsh Biopharmoration can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tsh Biopharmoration will offset losses from the drop in Tsh Biopharmoration's long position.

The idea behind Progate Group and tsh biopharmoration pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.